These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3129508)

  • 1. Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation.
    Wahl SM; Hunt DA; Wong HL; Dougherty S; McCartney-Francis N; Wahl LM; Ellingsworth L; Schmidt JA; Hall G; Roberts AB
    J Immunol; 1988 May; 140(9):3026-32. PubMed ID: 3129508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A; Bell GI; Director EP
    J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
    Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
    J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factors beta slow down cell-cycle progression in a murine interleukin-2 dependent T-cell line.
    Stoeck M; Miescher S; MacDonald HR; Von Fliedner V
    J Cell Physiol; 1989 Oct; 141(1):65-73. PubMed ID: 2789227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
    Kehrl JH; Roberts AB; Wakefield LM; Jakowlew S; Sporn MB; Fauci AS
    J Immunol; 1986 Dec; 137(12):3855-60. PubMed ID: 2878044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of transforming growth factor-beta on early and late activation events in human T cells.
    Ahuja SS; Paliogianni F; Yamada H; Balow JE; Boumpas DT
    J Immunol; 1993 Apr; 150(8 Pt 1):3109-18. PubMed ID: 8468460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta inhibits human T-cell proliferation through multiple targets.
    Fox FE; Capocasale RJ; Ford HC; Lamb RJ; Moore JS; Nowell PC
    Lymphokine Cytokine Res; 1992 Dec; 11(6):299-305. PubMed ID: 1477183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties.
    Arend WP; Joslin FG; Thompson RC; Hannum CH
    J Immunol; 1989 Sep; 143(6):1851-8. PubMed ID: 2528582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation.
    Granstein RD; Staszewski R; Knisely TL; Zeira E; Nazareno R; Latina M; Albert DM
    J Immunol; 1990 Apr; 144(8):3021-7. PubMed ID: 2324494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta mediates IL-1-dependent induction of IL-1 receptor antagonist.
    Wahl SM; Costa GL; Corcoran M; Wahl LM; Berger AE
    J Immunol; 1993 Apr; 150(8 Pt 1):3553-60. PubMed ID: 8468489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting effect of transforming growth factor type beta 1 (TGF-beta 1) on proliferation and interleukin-2 receptor expression in activated and rapidly cycling immature (CD3-CD4-CD8-) thymocytes.
    Dupuy d'Angeac A; Rème T; Monier S; Gao Q; Duperray C; Jullien P; Dornand J
    J Cell Physiol; 1993 Jan; 154(1):44-52. PubMed ID: 8419406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
    Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
    J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-10 synergizes with dexamethasone in inhibiting human T cell proliferation.
    Brunetti M; Colasante A; Mascetra N; Piantelli M; Musiani P; Aiello FB
    J Pharmacol Exp Ther; 1998 May; 285(2):915-9. PubMed ID: 9580644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28 co-stimulation regulates the effect of transforming growth factor-beta1 on the proliferation of naïve CD4+ T cells.
    Sung JL; Lin JT; Gorham JD
    Int Immunopharmacol; 2003 Feb; 3(2):233-45. PubMed ID: 12586604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.
    Espevik T; Figari IS; Ranges GE; Palladino MA
    J Immunol; 1988 Apr; 140(7):2312-6. PubMed ID: 3280680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
    Fernandez-Pol JA; Klos DJ; Grant GA
    Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells.
    Saito S; Morii T; Enomoto M; Sakakura S; Nishikawa K; Narita N; Ichijo M
    Cell Immunol; 1993 Dec; 152(2):605-13. PubMed ID: 7504983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells.
    Geissmann F; Revy P; Regnault A; Lepelletier Y; Dy M; Brousse N; Amigorena S; Hermine O; Durandy A
    J Immunol; 1999 Apr; 162(8):4567-75. PubMed ID: 10201996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor T cell-activating macrophages in ultraviolet-irradiated human skin induce a novel, TGF-beta-dependent form of T cell activation characterized by deficient IL-2r alpha expression.
    Stevens SR; Shibaki A; Meunier L; Cooper KD
    J Immunol; 1995 Dec; 155(12):5601-7. PubMed ID: 7499843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.